These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4093212)

  • 1. Three therapeutic communities for drug abusers: differences in treatment environments.
    Bell MD
    Int J Addict; 1985 Oct; 20(10):1523-31. PubMed ID: 4093212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptoms and mentally ill chemical abusers' perception of the treatment environment in residential settings.
    Nuttbrock LA; Rahav MR; Rivera JJ; Ng-Mak DS
    Addict Behav; 1999; 24(1):139-44. PubMed ID: 10189982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMPI patterns in drug abusers before and after treatment in therapeutic communities.
    Zuckerman M; Sola S; Masterson J; Angelone JV
    J Consult Clin Psychol; 1975 Jun; 43(3):286-96. PubMed ID: 1159116
    [No Abstract]   [Full Text] [Related]  

  • 4. The impact of a social network intervention on retention in Belgian therapeutic communities: a quasi-experimental study.
    Soyez V; De Leon G; Broekaert E; Rosseel Y
    Addiction; 2006 Jul; 101(7):1027-34. PubMed ID: 16771894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of participants in a drug dependence therapeutic community.
    Romond AM; Forrest CK; Kleber HD
    Arch Gen Psychiatry; 1975 Mar; 32(3):369-74. PubMed ID: 1122171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Therapeutic Community Involvement Scale: an instrument for assessing the staff perceptions of the therapeutic involvement of illicit drug abusers.
    Mitchell S; Page RC
    Int J Addict; 1987 Oct; 22(10):1041-8. PubMed ID: 3692630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Retention in Therapeutic Communities for Substance Abuse Treatment: An Organizational-Environmental-Professional Perspective.
    Levin L; Teichman M
    Soc Work; 2017 Apr; 62(2):165-173. PubMed ID: 28184911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparisons of perceptions of the environments of adolescent drug treatment residential and outpatient programs by staff versus clients and by sex of staff and clients.
    Friedman AS; Glickman NW; Kovach JA
    Am J Drug Alcohol Abuse; 1986; 12(1-2):31-52. PubMed ID: 3788898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distress tolerance as a predictor of early treatment dropout in a residential substance abuse treatment facility.
    Daughters SB; Lejuez CW; Bornovalova MA; Kahler CW; Strong DR; Brown RA
    J Abnorm Psychol; 2005 Nov; 114(4):729-34. PubMed ID: 16351393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Male and female drug abusers: social and psychological status 2 years after treatment in a therapeutic community.
    De Leon G; Jainchill N
    Am J Drug Alcohol Abuse; 1981-1982; 8(4):465-97. PubMed ID: 7348107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment Protocol Effectiveness Study. A White Paper of the Office of National Drug Control Policy Barry R. McCaffrey, Director March, 1996. Treatment Outcome Working Group.
    J Subst Abuse Treat; 1996; 13(4):295-319. PubMed ID: 9076649
    [No Abstract]   [Full Text] [Related]  

  • 12. Program-based evaluation research in therapeutic communities.
    De Leon G
    NIDA Res Monogr; 1984; 51():69-87. PubMed ID: 6438519
    [No Abstract]   [Full Text] [Related]  

  • 13. Alcohol use among drug abusers: treatment outcome in a therapeutic community.
    De Leon G
    Alcohol Clin Exp Res; 1987 Oct; 11(5):430-6. PubMed ID: 3314555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of four treatment approaches in community residential programs for patients with substance use disorders.
    Moos RH; Moos BS; Andrassy JM
    Psychiatr Serv; 1999 Dec; 50(12):1577-83. PubMed ID: 10577876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention in drug-free therapeutic communities.
    De Leon G
    NIDA Res Monogr; 1991; 106():218-44. PubMed ID: 1922289
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic communities: what are the retention rates?
    De Leon G; Schwartz S
    Am J Drug Alcohol Abuse; 1984; 10(2):267-84. PubMed ID: 6475892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gateway Houses: effectiveness of treatment on criminal behavior.
    Holland S
    Int J Addict; 1978 Apr; 13(3):369-81. PubMed ID: 669861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family therapy and reductions in treatment dropout in a residential therapeutic community for chemically dependent adolescents.
    Weidman A
    J Subst Abuse Treat; 1987; 4(1):21-8. PubMed ID: 3612889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mindfulness-based stress reduction in therapeutic community treatment: a stage 1 trial.
    Marcus MT; Schmitz J; Moeller G; Liehr P; Cron SG; Swank P; Bankston S; Carroll DD; Granmayeh LK
    Am J Drug Alcohol Abuse; 2009; 35(2):103-8. PubMed ID: 19322731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personality and coping styles in the prediction of dropout from treatment for cocaine abuse.
    McMahon RC; Kelley A; Kouzekanani K
    J Pers Assess; 1993 Aug; 61(1):147-55. PubMed ID: 8377099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.